|
|
Volumn 53, Issue 5, 2012, Pages 2456-2460
|
|
Section I: Executive summary key needs and opportunities for treating glaucoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOXIDANT;
NANOPARTICLE;
NEUROTROPHIC FACTOR;
AGING;
APOPTOSIS;
ARTICLE;
CDKN2BAS GENE;
CELL DEATH;
DIABETIC RETINOPATHY;
EARLY DIAGNOSIS;
ENVIRONMENTAL FACTOR;
EPIGENETICS;
GENE;
GENE MUTATION;
GENE THERAPY;
GLAUCOMA;
HEREDITY;
HUMAN;
IMAGING;
IMMUNOTHERAPY;
INTRAOCULAR PRESSURE;
NERVE DEGENERATION;
NEUROPATHY;
NONHUMAN;
OPTIC NERVE;
PREVALENCE;
PRIORITY JOURNAL;
RETINA GANGLION CELL;
RETINA MACULA AGE RELATED DEGENERATION;
RETINITIS PIGMENTOSA;
TELEMEDICINE;
TRABECULAR MESHWORK;
CONSENSUS DEVELOPMENT;
HEALTH SERVICE;
MEDICAL RESEARCH;
BIOMEDICAL RESEARCH;
CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC;
GLAUCOMA;
HEALTH SERVICES NEEDS AND DEMAND;
HUMANS;
|
|
EID: 84860612603
PISSN: 01460404
EISSN: 15525783
Source Type: Journal
DOI: 10.1167/iovs.12-9483a Document Type: Article |
|
Times cited : (7)
|
|
References (1)
|
